2nd Annual CNS Oncology Conference: Advances in Primary and Metastatic Brain Tumors

Overview

Brain metastasis represents a significant and growing challenge in oncology, with patients often facing complex diagnostic and therapeutic hurdles. Despite recent advances, there remain unmet needs in early detection, optimal treatment selection, and coordination of multidisciplinary care.

This live, interactive symposium will feature expert-led presentations and case-based panel discussions, providing participants with the latest updates and practical strategies for managing brain metastases. The program will be held in conjunction with the 24th Annual Miami Lung Cancer Conference, offering attendees a unique opportunity to engage with leaders in both brain metastasis and lung cancer care, and to foster collaboration across specialties dedicated to improving patient outcomes.

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669.

Medical Oncologists (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

There are several opportunities (both continuing education [CE] and non-CE) available for companies, associations, and societies interested in supporting this year's conference.

For Continuing Education, Associations, and Societies

Please email [email protected] for information about this upcoming conference.

Exhibitors

Exhibit at this year’s meeting and increase your visibility. Our custom sponsorship packages provide outstanding recognition and increased awareness of your company’s products and services. Don’t miss this opportunity to reach this important target audience.

For additional details, contact:

Elisha Ball | Associate Director of Sales
OncLive^® Events & Intellisphere Oncology Specialty Group
Cell: (610) 563-1620
Email: [email protected]

Maddison Martini | National Accounts Associate
OncLive^® Events & Intellisphere Oncology Specialty Group
Cell: (609) 947-8377
Email: [email protected]

OncLive^® Events & Intellisphere Oncology Specialty Group
259 Prospect Plains Rd, Building H, Monroe, NJ 08831
Web: http://www.onclive.com

Advisory Board or Ancillary Meeting Definition

Any meeting whose invited participants are professional attendees of the Conference, such as doctors and physicians will be considered an Advisory Board (Ad Board) or Ancillary Meeting. This includes activities such as round-table discussions, investigator meetings, social gatherings and meet the specialist‐type meetings.

A fee is applicable for hosting these meetings, with the amount being dependent on the type and size of your meeting.

Blackout Times

There are many programs being scheduled throughout our conferences. With that, the black out hours across our meeting are as follows:

• One day prior to the conferences
• The duration of the conference
• One day post conference

To review your meeting request, please contact Elisha Ball or Maddison Martini.

A cancellation fee of 25% will be assessed on refunds requested 90 days before the start date, a 50% fee on refunds requested 60 days before the start date, and a 75% fee on refunds requested 30 days before the start date. No refunds will be made after 30 days before the start date. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

PER^® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.